Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Angel Cosme

Showing results (31-40 of 46) with videos related to

Pageof 5
Sort By:
Medicina Clinica|September 22, 2009
[Clinicopathological characteristics and survival outcome of esophageal cancer. Results from a series of 200 patients]Luis Bujanda, Inés Gil, Cristina Sarasqueta, et al.
Plos One|January 10, 2013
Evaluation of alpha 1-antitrypsin and the levels of mRNA expression of matrix metalloproteinase 7, urokinase type plasminogen activator receptor and COX-2 for the diagnosis of colorectal cancerLuis Bujanda, Cristina Sarasqueta, Angel Cosme, et al.
The American Journal of Gastroenterology|February 4, 2006
Third-line rescue therapy with levofloxacin after two H. pylori treatment failuresJavier P Gisbert, Manuel Castro-Fernández, Fernando Bermejo, et al.
Mayo Clinic Proceedings|June 12, 2013
Effect of aspirin and antiplatelet drugs on the outcome of the fecal immunochemical testLuis Bujanda, Ángel Lanas, Enrique Quintero, et al.
Digestive Diseases and Sciences|April 4, 2007
Molecular and clinical characteristics in 46 families affected with Peutz-Jeghers syndromeHamid Mehenni, Nicoletta Resta, Ginevra Guanti, et al.
Digestive Diseases and Sciences|September 20, 2014
Helicobacter pylori first-line and rescue treatments in the presence of penicillin allergyJavier P Gisbert, Jesús Barrio, Inés Modolell, et al.
Helicobacter|May 29, 2004
The prevalence of peptic ulcer not related to Helicobacter pylori or non-steroidal anti-inflammatory drug use is negligible in southern EuropeM Teresa Arroyo, Montse Forne, Carlos Martin de Argila, et al.
Helicobacter|August 3, 2007
Eradication of Helicobacter pylori for the prevention of peptic ulcer rebleedingJavier P Gisbert, Xavier Calvet, Faust Feu, et al.
World Journal of Gastroenterology|February 10, 2010
Colorectal cancer prognosis twenty years laterLuis Bujanda, Cristina Sarasqueta, Elisabeth Hijona, et al.
Journal of Clinical Gastroenterology|June 1, 2012
Second-line therapy with levofloxacin after failure of treatment to eradicate helicobacter pylori infection: time trends in a Spanish Multicenter Study of 1000 patientsJavier P Gisbert, Angeles Pérez-Aisa, Fernando Bermejo, et al.
Pageof 5

Showing results (31-40 of 46) with videos related to

Sort By:
Pageof 5
Medicina Clinica|September 22, 2009
[Clinicopathological characteristics and survival outcome of esophageal cancer. Results from a series of 200 patients]Luis Bujanda, Inés Gil, Cristina Sarasqueta, et al.
Plos One|January 10, 2013
Evaluation of alpha 1-antitrypsin and the levels of mRNA expression of matrix metalloproteinase 7, urokinase type plasminogen activator receptor and COX-2 for the diagnosis of colorectal cancerLuis Bujanda, Cristina Sarasqueta, Angel Cosme, et al.
The American Journal of Gastroenterology|February 4, 2006
Third-line rescue therapy with levofloxacin after two H. pylori treatment failuresJavier P Gisbert, Manuel Castro-Fernández, Fernando Bermejo, et al.
Mayo Clinic Proceedings|June 12, 2013
Effect of aspirin and antiplatelet drugs on the outcome of the fecal immunochemical testLuis Bujanda, Ángel Lanas, Enrique Quintero, et al.
Digestive Diseases and Sciences|April 4, 2007
Molecular and clinical characteristics in 46 families affected with Peutz-Jeghers syndromeHamid Mehenni, Nicoletta Resta, Ginevra Guanti, et al.
Digestive Diseases and Sciences|September 20, 2014
Helicobacter pylori first-line and rescue treatments in the presence of penicillin allergyJavier P Gisbert, Jesús Barrio, Inés Modolell, et al.
Helicobacter|May 29, 2004
The prevalence of peptic ulcer not related to Helicobacter pylori or non-steroidal anti-inflammatory drug use is negligible in southern EuropeM Teresa Arroyo, Montse Forne, Carlos Martin de Argila, et al.
Helicobacter|August 3, 2007
Eradication of Helicobacter pylori for the prevention of peptic ulcer rebleedingJavier P Gisbert, Xavier Calvet, Faust Feu, et al.
World Journal of Gastroenterology|February 10, 2010
Colorectal cancer prognosis twenty years laterLuis Bujanda, Cristina Sarasqueta, Elisabeth Hijona, et al.
Journal of Clinical Gastroenterology|June 1, 2012
Second-line therapy with levofloxacin after failure of treatment to eradicate helicobacter pylori infection: time trends in a Spanish Multicenter Study of 1000 patientsJavier P Gisbert, Angeles Pérez-Aisa, Fernando Bermejo, et al.
Pageof 5